Donald Healey
Fortune : 29 825 $ au 30/06/2026
Fortune : 29 825 $ au 30/06/2026
Donald Healey currently works at Adicet Bio, Inc., as Chief Technology Officer from 2020.
Dr. Healey also formerly worked at Argos Therapeutics, Inc., as Director-Immunology, KBI Biopharma, Inc., as Senior Vice President-Operations from 2017 to 2020, Opexa Therapeutics, Inc., as Chief Scientific Officer from 2013 to 2017, and British Society for Immunology, as Council Member in 1998.
Dr. Healey received his doctorate degree from the University of London and undergraduate degree from the University of Bristol.
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
ADICET BIO INC 0,04% | 25/03/2026 | 3 452 ( 0,04% ) | 29 825 $ | 30/06/2026 |
| Sociétés | Poste | Début |
|---|---|---|
| ADICET BIO, INC. | Directeur Technique/Scientifique/R&D | 26/10/2020 |
| Sociétés | Poste | Fin |
|---|---|---|
KBI Biopharma, Inc.
KBI Biopharma, Inc. Miscellaneous Commercial ServicesCommercial Services Provides drug development and contract manufacturing services | Directeur des opérations | 01/10/2020 |
Opexa Therapeutics, Inc.
Opexa Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops autologous personalized cell therapies for the treatment of various diseases. | Directeur Technique/Scientifique/R&D | 01/02/2017 |
British Society for Immunology
British Society for Immunology Miscellaneous Commercial ServicesCommercial Services Provides membership organizations services | Corporate Officer/Principal | 01/01/1998 |
| ARGOS THERAPEUTICS, INC. | Corporate Officer/Principal | - |
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
| Entreprise privées | 7 |
|---|---|
KBI Biopharma, Inc.
KBI Biopharma, Inc. Miscellaneous Commercial ServicesCommercial Services Provides drug development and contract manufacturing services | Commercial Services |
Argos Therapeutics, Inc.
Argos Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes personalized immunotherapies for the treatment of cancer and infectious diseases | Health Technology |
University of London
University of London Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of Bristol
University of Bristol Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Opexa Therapeutics, Inc.
Opexa Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops autologous personalized cell therapies for the treatment of various diseases. | Health Technology |
British Society for Immunology
British Society for Immunology Miscellaneous Commercial ServicesCommercial Services Provides membership organizations services | Commercial Services |
Adicet Bio, Inc.
Adicet Bio, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company focused on the development of cell immunotherapies | Health Technology |
Sélectionnez votre édition
Toutes les informations financières adaptées au niveau national